Anila Lingamneni - Net Worth and Insider Trading

Anila Lingamneni Net Worth

The estimated net worth of Anila Lingamneni is at least $2 Million dollars as of 2024-12-28. Anila Lingamneni is the EVP, Chief Technology Officer of Haemonetics Corp and owns about 21,331 shares of Haemonetics Corp (HAE) stock worth over $2 Million. Details can be seen in Anila Lingamneni's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Anila Lingamneni has not made any transactions after 2024-07-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Anila Lingamneni

To

Anila Lingamneni Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Anila Lingamneni owns 1 companies in total, including Haemonetics Corp (HAE) .

Click here to see the complete history of Anila Lingamneni’s form 4 insider trades.

Insider Ownership Summary of Anila Lingamneni

Ticker Comapny Transaction Date Type of Owner
HAE Haemonetics Corp 2024-07-12 EVP & Chief Technology Officer

Anila Lingamneni Latest Holdings Summary

Anila Lingamneni currently owns a total of 1 stock. Anila Lingamneni owns 21,331 shares of Haemonetics Corp (HAE) as of July 12, 2024, with a value of $2 Million.

Latest Holdings of Anila Lingamneni

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HAE Haemonetics Corp 2024-07-12 21,331 77.57 1,654,646

Holding Weightings of Anila Lingamneni


Anila Lingamneni Form 4 Trading Tracker

According to the SEC Form 4 filings, Anila Lingamneni has made a total of 8 transactions in Haemonetics Corp (HAE) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Haemonetics Corp is the sale of 2,215 shares on July 12, 2024, which brought Anila Lingamneni around $199,350.

Insider Trading History of Anila Lingamneni

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Anila Lingamneni Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Anila Lingamneni Ownership Network

Ownership Network List of Anila Lingamneni

No Data

Ownership Network Relation of Anila Lingamneni

Insider Network Chart

Anila Lingamneni Owned Company Details

What does Haemonetics Corp do?

Who are the key executives at Haemonetics Corp?

Anila Lingamneni is the EVP & Chief Technology Officer of Haemonetics Corp. Other key executives at Haemonetics Corp include President & Global Hospital Stewart W Strong , EVP and General Counsel Michelle L Basil , and EVP & Global Manufacturing Josep Llorens .

Haemonetics Corp (HAE) Insider Trades Summary

Over the past 18 months, Anila Lingamneni made 3 insider transaction in Haemonetics Corp (HAE) with a net sale of 6,825. Other recent insider transactions involving Haemonetics Corp (HAE) include a net sale of 14,816 shares made by Stewart W Strong , a net sale of 16,652 shares made by Michelle L Basil , and a net sale of 7,507 shares made by Josep Llorens .

In summary, during the past 3 months, insiders sold 0 shares of Haemonetics Corp (HAE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 56,015 shares of Haemonetics Corp (HAE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 56,015 shares.

Haemonetics Corp (HAE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Haemonetics Corp Insider Transactions

No Available Data

Anila Lingamneni Mailing Address

Above is the net worth, insider trading, and ownership report for Anila Lingamneni. You might contact Anila Lingamneni via mailing address: Haemonetics Corporation, 125 Summer Street, Boston Ma 02110.

Discussions on Anila Lingamneni

No discussions yet.